UBS Group’s National Vision EYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Hold
100,000
﹤0.01% 5148
2026
Q1
$2.59M Buy
+100,000
New +$2.72M ﹤0.01% 4730
2018
Q4
Sell
-11,500
Closed -$519K 8101
2018
Q3
$519K Sell
11,500
-26,000
-69% -$1.1M ﹤0.01% 4368
2018
Q2
$1.37M Buy
+37,500
New +$1.31M ﹤0.01% 3503

Other funds holding EYE

UBS Group's EYE Position: Q2 2026 in Review

UBS Group reduced its National Vision (EYE) stake by 53% in Q2 2026, selling an estimated $9.36M and leaving 399,642 shares worth $7.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3751.

UBS Group first reported a position in EYE in Q4 2017 and has held it in 35 quarters since. The position peaked at $22.2M in Q1 2026. 232 funds tracked by Wall St. Rank hold EYE as of Q2 2026.

  • UBS Group held 399,642 shares of National Vision worth $7.6M as of Q2 2026.
  • UBS Group sold 459,162 National Vision shares in Q2 2026, an estimated $9.36M.
  • National Vision made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3751 holding.
  • UBS Group first reported a position in National Vision in Q4 2017 and has held it in 35 quarters since.
  • UBS Group's National Vision position peaked at $22.2M in Q1 2026.
  • 232 funds tracked by Wall St. Rank held National Vision as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.